v3.25.1
REVENUES (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]      
Deferred Revenue, Revenue Recognized $ 68.9 $ 51.0  
Financing Receivable, Allowance for Credit Loss [Line Items]      
Allowance for Credit Loss, Write Off (7.0)    
Allowance for Credit Loss, Receivable, Other, Current (7.5)   $ (7.6)
Accounts receivable, net 2,123.2   1,944.1
Contract with Customer, Asset, after Allowance for Credit Loss, Current 151.3   152.9
Contract with Customer, Asset, before Allowance for Credit Loss 158.8   160.5
Accounts Receivable, Allowance for Credit Loss 38.6   44.7
Allowance for Credit Loss, Foreign Currency Translation Impact 0.8    
Unbilled Services, Foreign Currency Translation Impact 0.1    
Unbilled Services, Allowance for Credit Loss 7.5   7.6
Allowance for Credit Loss 46.1   52.3
Accounts Receivable, Credit Loss Expense (Reversal) 0.7    
Diagnostics      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Accounts Receivable, before Allowance for Credit Loss 1,403.2   1,259.3
Biopharma Laboratory Services      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Accounts Receivable, before Allowance for Credit Loss 758.6   $ 729.5
Accounts Receivable [Member]      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Allowance for Credit Loss, Write Off (6.8)    
Unbilled Contracts Receivable [Member]      
Financing Receivable, Allowance for Credit Loss [Line Items]      
Allowance for Credit Loss, Write Off $ (0.2)